ACE Inhibitors and ARBs Do Not Increase Risk of Severe/Lethal COVID-19 ACE Inhibitors and ARBs Do Not Increase Risk of Severe/Lethal COVID-19

Angiotensin converting-enzyme inhibitors and angiotensin receptor blockers do not increase the risk of severe or lethal COVID-19, according to a meta-analysis.Reuters Health Information

Source: Medscape Medical News Headlines - July 10, 2020 Category: Consumer Health News Tags: Cardiology News Source Type: news